+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
IOLCP

IOL Chemicals and Pharmaceuticals Share Price

₹204.19 +0.97 (0.48%)
203.90% Gain from 52W Low

25 Sep, 2026 3:59 PM (IST)

IOL Chemicals and Pharmaceuticals live price: ₹204.19. It opened at ₹203 vs previous close ₹203; intraday high/low: ₹207/₹198. The 50 & 200 DMA stand at ₹179.60/₹133.20.

IOL Chemicals and Pharmaceuticals Performance

  • Today's Low
  • ₹198
  • Today's High
  • ₹207
  • 52 Week Low
  • ₹67
  • 52 Week High
  • ₹219
  • Open Price₹203
  • Previous Close₹203
  • Volume2,643,509
  • 50 DMA₹179.60
  • 100 DMA₹157.80
  • 200 DMA₹133.20

IOL Chemicals and Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 9.77%
  • Over 3 Month + 52.77%
  • Over 6 Month + 159.82%
  • Over 1 Year + 96.58%

Smart Investing Starts Here Start SIP with IOL Chemicals and Pharmaceuticals for Steady Growth!

Invest Now

IOL Chemicals and Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.7
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 5,994
  • P/B Ratio
  • 3.2
  • Average True Range
  • 11.6
  • EPS
  • 5.7
  • Dividend Yield
  • 0.5
  • MACD Signal
  • 7.7
  • RSI
  • 58.93
  • MFI
  • 63.42

Latest Stock News Updates

IOL Chemicals & Pharmaceuticals Ltd - 524164 - Grant Of Certificate Of Suitability (CEP) For Fenofibrate - Process II

CEP for Fenofibrate - Process II

IOL Chemicals & Pharmaceuticals Ltd - 524164 - Closure of Trading Window

Intimation of Closure of Trading Window

IOL Chemicals & Pharmaceuticals Ltd - 524164 - EU-REACH Registration For Triacetin

EU-REACH Registration for Triacetin

IOL Chemicals and Pharmaceuticals Financials

IOL Chemicals and Pharmaceuticals Technicals

EMA & SMA

Current Price
₹204.19
+ 0.97 (0.48%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹196.30
  • 50 Day
  • ₹179.60
  • 100 Day
  • ₹157.80
  • 200 Day
  • ₹133.20

Resistance and Support

202.9 Pivot Speed
  • R3 216.30
  • R2 211.40
  • R1 207.80
  • S1 199.30
  • S2 194.40
  • S3 190.80

IOL Chemicals and Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-10 Quarterly Results
2026-05-20 Audited Results
2026-02-11 Quarterly Results & Interim Dividend
2025-11-11 Quarterly Results
2025-08-07 Quarterly Results
Date Purpose Remarks
2026-02-17 INTERIM Rs.1.00 per share(50%)Interim Dividend
2025-02-18 INTERIM Rs.4.00 per share(40%)Interim Dividend
2024-02-16 INTERIM Rs.5.00 per share(50%)Interim Dividend
2023-02-17 INTERIM Rs.4.00 per share(40%)Interim Dividend
2022-02-16 INTERIM Rs.4.00 per share(40%)Interim Dividend
View IOL Chemicals and Pharmaceuticals Dividend History Arrow
Date Purpose Remarks
2025-03-11 Split Stock split from Rs. 10/- to Rs. 2/-.

IOL Chemicals and Pharmaceuticals Shareholding Pattern

62.28%
32.41%
4.87%
0.41%
0.02%

About IOL Chemicals and Pharmaceuticals

IOL Chemicals & Pharmaceuticals is engaged in the manufacturing and selling of Pharmaceutical and Chemical products. The company caters to both domestic and international market View More
  • NSE Symbol
  • IOLCP
  • BSE Symbol
  • 524164
  • ISIN
  • INE485C01029

Similar Stocks to IOL Chemicals and Pharmaceuticals

IOL Chemicals and Pharmaceuticals FAQs

IOL Chemicals and Pharmaceuticals share price is ₹204 As on 27 September, 2026 | 07:19

The Market Cap of IOL Chemicals and Pharmaceuticals is ₹5993.5 Cr As on 27 September, 2026 | 07:19

The P/E ratio of IOL Chemicals and Pharmaceuticals is 35.7 As on 27 September, 2026 | 07:19

The PB ratio of IOL Chemicals and Pharmaceuticals is 3.2 As on 27 September, 2026 | 07:19

The 52 week High & Low of IOL Chemicals and Pharmaceuticals is ₹219/₹67.2 respectively As on 27 September, 2026 | 07:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23